nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—Temsirolimus—kidney cancer	0.0654	0.169	CbGbCtD
Fingolimod—CYP3A4—Everolimus—kidney cancer	0.0616	0.159	CbGbCtD
Fingolimod—CYP3A4—Temsirolimus—kidney cancer	0.0416	0.108	CbGbCtD
Fingolimod—CYP2D6—Pazopanib—kidney cancer	0.0343	0.0889	CbGbCtD
Fingolimod—CYP2D6—Erlotinib—kidney cancer	0.0245	0.0635	CbGbCtD
Fingolimod—CYP3A4—Pazopanib—kidney cancer	0.0218	0.0565	CbGbCtD
Fingolimod—CYP2D6—Sorafenib—kidney cancer	0.0199	0.0516	CbGbCtD
Fingolimod—CYP2D6—Vinblastine—kidney cancer	0.0197	0.0509	CbGbCtD
Fingolimod—CYP3A4—Erlotinib—kidney cancer	0.0156	0.0404	CbGbCtD
Fingolimod—CYP3A4—Paclitaxel—kidney cancer	0.0143	0.0369	CbGbCtD
Fingolimod—CYP3A4—Sorafenib—kidney cancer	0.0127	0.0328	CbGbCtD
Fingolimod—CYP3A4—Vinblastine—kidney cancer	0.0125	0.0324	CbGbCtD
Fingolimod—CYP3A4—Vincristine—kidney cancer	0.0123	0.0319	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—kidney cancer	0.0121	0.0313	CbGbCtD
Fingolimod—CYP3A4—Sunitinib—kidney cancer	0.0103	0.0266	CbGbCtD
Fingolimod—CYP4F2—nephron tubule—kidney cancer	0.00948	0.09	CbGeAlD
Fingolimod—CYP4F2—renal system—kidney cancer	0.00862	0.0818	CbGeAlD
Fingolimod—CYP4F2—kidney—kidney cancer	0.00833	0.0791	CbGeAlD
Fingolimod—CYP4F2—cortex of kidney—kidney cancer	0.00812	0.077	CbGeAlD
Fingolimod—CYP3A4—Doxorubicin—kidney cancer	0.00769	0.0199	CbGbCtD
Fingolimod—CYP4F12—nephron tubule—kidney cancer	0.00705	0.0669	CbGeAlD
Fingolimod—S1PR3—gonad—kidney cancer	0.00686	0.0651	CbGeAlD
Fingolimod—S1PR3—cardiac atrium—kidney cancer	0.00685	0.065	CbGeAlD
Fingolimod—SPHK1—renal system—kidney cancer	0.00667	0.0633	CbGeAlD
Fingolimod—SPHK1—kidney—kidney cancer	0.00645	0.0612	CbGeAlD
Fingolimod—CYP4F12—cortex of kidney—kidney cancer	0.00603	0.0573	CbGeAlD
Fingolimod—SPHK1—gonad—kidney cancer	0.00598	0.0568	CbGeAlD
Fingolimod—CYP4F12—cardiac atrium—kidney cancer	0.00574	0.0545	CbGeAlD
Fingolimod—CYP2E1—urine—kidney cancer	0.00442	0.0419	CbGeAlD
Fingolimod—CYP3A4—urine—kidney cancer	0.00355	0.0337	CbGeAlD
Fingolimod—CYP2D6—urine—kidney cancer	0.0035	0.0332	CbGeAlD
Fingolimod—CYP2E1—nephron tubule—kidney cancer	0.00119	0.0113	CbGeAlD
Fingolimod—CYP2E1—renal system—kidney cancer	0.00108	0.0103	CbGeAlD
Fingolimod—CYP2E1—kidney—kidney cancer	0.00104	0.00991	CbGeAlD
Fingolimod—CYP2E1—cortex of kidney—kidney cancer	0.00102	0.00966	CbGeAlD
Fingolimod—CYP3A4—renal system—kidney cancer	0.000869	0.00825	CbGeAlD
Fingolimod—CYP2D6—renal system—kidney cancer	0.000855	0.00812	CbGeAlD
Fingolimod—CYP3A4—kidney—kidney cancer	0.00084	0.00798	CbGeAlD
Fingolimod—CYP2D6—kidney—kidney cancer	0.000827	0.00785	CbGeAlD
Fingolimod—Pneumonia—Gemcitabine—kidney cancer	0.000458	0.00155	CcSEcCtD
Fingolimod—Liver function test abnormal—Paclitaxel—kidney cancer	0.000456	0.00155	CcSEcCtD
Fingolimod—Alopecia—Sunitinib—kidney cancer	0.00045	0.00152	CcSEcCtD
Fingolimod—Eye pain—Capecitabine—kidney cancer	0.000449	0.00152	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000449	0.00152	CcSEcCtD
Fingolimod—Cough—Erlotinib—kidney cancer	0.000447	0.00151	CcSEcCtD
Fingolimod—Mental disorder—Sunitinib—kidney cancer	0.000446	0.00151	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Paclitaxel—kidney cancer	0.000445	0.00151	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Paclitaxel—kidney cancer	0.000436	0.00148	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000433	0.00147	CcSEcCtD
Fingolimod—Infection—Everolimus—kidney cancer	0.00043	0.00146	CcSEcCtD
Fingolimod—Back pain—Sunitinib—kidney cancer	0.000429	0.00145	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—kidney cancer	0.000428	0.00145	CcSEcCtD
Fingolimod—Influenza—Paclitaxel—kidney cancer	0.000427	0.00145	CcSEcCtD
Fingolimod—Alopecia—Dactinomycin—kidney cancer	0.000426	0.00144	CcSEcCtD
Fingolimod—Nervous system disorder—Everolimus—kidney cancer	0.000425	0.00144	CcSEcCtD
Fingolimod—Connective tissue disorder—Vincristine—kidney cancer	0.000423	0.00143	CcSEcCtD
Fingolimod—Skin disorder—Everolimus—kidney cancer	0.000421	0.00143	CcSEcCtD
Fingolimod—Asthenia—Temsirolimus—kidney cancer	0.000418	0.00142	CcSEcCtD
Fingolimod—Infection—Erlotinib—kidney cancer	0.000415	0.00141	CcSEcCtD
Fingolimod—Cerebrovascular accident—Capecitabine—kidney cancer	0.000414	0.0014	CcSEcCtD
Fingolimod—Leukopenia—Sorafenib—kidney cancer	0.000412	0.0014	CcSEcCtD
Fingolimod—Pruritus—Temsirolimus—kidney cancer	0.000412	0.0014	CcSEcCtD
Fingolimod—Bronchitis—Paclitaxel—kidney cancer	0.000411	0.00139	CcSEcCtD
Fingolimod—Nervous system disorder—Erlotinib—kidney cancer	0.00041	0.00139	CcSEcCtD
Fingolimod—Skin disorder—Erlotinib—kidney cancer	0.000406	0.00138	CcSEcCtD
Fingolimod—Hypotension—Everolimus—kidney cancer	0.000405	0.00137	CcSEcCtD
Fingolimod—Cough—Sorafenib—kidney cancer	0.000402	0.00136	CcSEcCtD
Fingolimod—Connective tissue disorder—Gemcitabine—kidney cancer	0.000401	0.00136	CcSEcCtD
Fingolimod—Cardiac disorder—Vincristine—kidney cancer	0.0004	0.00135	CcSEcCtD
Fingolimod—Migraine—Capecitabine—kidney cancer	0.000399	0.00135	CcSEcCtD
Fingolimod—Diarrhoea—Temsirolimus—kidney cancer	0.000398	0.00135	CcSEcCtD
Fingolimod—Hypertension—Sorafenib—kidney cancer	0.000398	0.00135	CcSEcCtD
Fingolimod—Leukopenia—Sunitinib—kidney cancer	0.000397	0.00134	CcSEcCtD
Fingolimod—Asthenia—Pazopanib—kidney cancer	0.000394	0.00133	CcSEcCtD
Fingolimod—Angiopathy—Vincristine—kidney cancer	0.000391	0.00132	CcSEcCtD
Fingolimod—Paraesthesia—Vinblastine—kidney cancer	0.00039	0.00132	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000389	0.00132	CcSEcCtD
Fingolimod—Paraesthesia—Everolimus—kidney cancer	0.000389	0.00132	CcSEcCtD
Fingolimod—Mediastinal disorder—Vincristine—kidney cancer	0.000388	0.00132	CcSEcCtD
Fingolimod—Pruritus—Pazopanib—kidney cancer	0.000388	0.00132	CcSEcCtD
Fingolimod—Cough—Sunitinib—kidney cancer	0.000387	0.00131	CcSEcCtD
Fingolimod—Weight decreased—Paclitaxel—kidney cancer	0.000387	0.00131	CcSEcCtD
Fingolimod—Dyspnoea—Everolimus—kidney cancer	0.000386	0.00131	CcSEcCtD
Fingolimod—Cardiac arrest—Capecitabine—kidney cancer	0.000386	0.00131	CcSEcCtD
Fingolimod—Dizziness—Temsirolimus—kidney cancer	0.000385	0.0013	CcSEcCtD
Fingolimod—Pneumonia—Paclitaxel—kidney cancer	0.000383	0.0013	CcSEcCtD
Fingolimod—Hypertension—Sunitinib—kidney cancer	0.000383	0.0013	CcSEcCtD
Fingolimod—Infestation—Paclitaxel—kidney cancer	0.000381	0.00129	CcSEcCtD
Fingolimod—Infestation NOS—Paclitaxel—kidney cancer	0.000381	0.00129	CcSEcCtD
Fingolimod—Alopecia—Vincristine—kidney cancer	0.000381	0.00129	CcSEcCtD
Fingolimod—Depression—Paclitaxel—kidney cancer	0.00038	0.00129	CcSEcCtD
Fingolimod—Cardiac disorder—Gemcitabine—kidney cancer	0.000379	0.00128	CcSEcCtD
Fingolimod—Mental disorder—Vincristine—kidney cancer	0.000377	0.00128	CcSEcCtD
Fingolimod—Leukopenia—Dactinomycin—kidney cancer	0.000376	0.00127	CcSEcCtD
Fingolimod—Diarrhoea—Pazopanib—kidney cancer	0.000375	0.00127	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000375	0.00127	CcSEcCtD
Fingolimod—Liver function test abnormal—Capecitabine—kidney cancer	0.000375	0.00127	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Everolimus—kidney cancer	0.000374	0.00127	CcSEcCtD
Fingolimod—Infection—Sorafenib—kidney cancer	0.000373	0.00127	CcSEcCtD
Fingolimod—Fatigue—Everolimus—kidney cancer	0.000373	0.00127	CcSEcCtD
Fingolimod—Dyspnoea—Erlotinib—kidney cancer	0.000373	0.00126	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—kidney cancer	0.000371	0.00126	CcSEcCtD
Fingolimod—Angiopathy—Gemcitabine—kidney cancer	0.000371	0.00126	CcSEcCtD
Fingolimod—Nervous system disorder—Sorafenib—kidney cancer	0.000369	0.00125	CcSEcCtD
Fingolimod—Mediastinal disorder—Gemcitabine—kidney cancer	0.000368	0.00125	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000365	0.00124	CcSEcCtD
Fingolimod—Skin disorder—Sorafenib—kidney cancer	0.000365	0.00124	CcSEcCtD
Fingolimod—Headache—Temsirolimus—kidney cancer	0.000365	0.00124	CcSEcCtD
Fingolimod—Dizziness—Pazopanib—kidney cancer	0.000363	0.00123	CcSEcCtD
Fingolimod—Back pain—Vincristine—kidney cancer	0.000363	0.00123	CcSEcCtD
Fingolimod—Alopecia—Gemcitabine—kidney cancer	0.000361	0.00122	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000361	0.00122	CcSEcCtD
Fingolimod—Fatigue—Erlotinib—kidney cancer	0.00036	0.00122	CcSEcCtD
Fingolimod—Infection—Sunitinib—kidney cancer	0.000359	0.00122	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.000358	0.00121	CcSEcCtD
Fingolimod—Sinusitis—Paclitaxel—kidney cancer	0.000357	0.00121	CcSEcCtD
Fingolimod—Nervous system disorder—Sunitinib—kidney cancer	0.000355	0.0012	CcSEcCtD
Fingolimod—Skin disorder—Sunitinib—kidney cancer	0.000351	0.00119	CcSEcCtD
Fingolimod—Influenza—Capecitabine—kidney cancer	0.000351	0.00119	CcSEcCtD
Fingolimod—Bradycardia—Paclitaxel—kidney cancer	0.000348	0.00118	CcSEcCtD
Fingolimod—Back pain—Gemcitabine—kidney cancer	0.000344	0.00117	CcSEcCtD
Fingolimod—Headache—Pazopanib—kidney cancer	0.000344	0.00116	CcSEcCtD
Fingolimod—Infection—Dactinomycin—kidney cancer	0.00034	0.00115	CcSEcCtD
Fingolimod—Bronchitis—Capecitabine—kidney cancer	0.000337	0.00114	CcSEcCtD
Fingolimod—Connective tissue disorder—Paclitaxel—kidney cancer	0.000336	0.00114	CcSEcCtD
Fingolimod—Leukopenia—Vincristine—kidney cancer	0.000336	0.00114	CcSEcCtD
Fingolimod—Dyspnoea—Sorafenib—kidney cancer	0.000335	0.00114	CcSEcCtD
Fingolimod—Paraesthesia—Sunitinib—kidney cancer	0.000325	0.0011	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000325	0.0011	CcSEcCtD
Fingolimod—Fatigue—Sorafenib—kidney cancer	0.000324	0.0011	CcSEcCtD
Fingolimod—Hypertension—Vincristine—kidney cancer	0.000324	0.0011	CcSEcCtD
Fingolimod—Dyspnoea—Sunitinib—kidney cancer	0.000323	0.00109	CcSEcCtD
Fingolimod—Eye disorder—Paclitaxel—kidney cancer	0.00032	0.00108	CcSEcCtD
Fingolimod—Leukopenia—Gemcitabine—kidney cancer	0.000318	0.00108	CcSEcCtD
Fingolimod—Cardiac disorder—Paclitaxel—kidney cancer	0.000317	0.00108	CcSEcCtD
Fingolimod—Weight decreased—Capecitabine—kidney cancer	0.000317	0.00108	CcSEcCtD
Fingolimod—Pneumonia—Capecitabine—kidney cancer	0.000315	0.00107	CcSEcCtD
Fingolimod—Infestation NOS—Capecitabine—kidney cancer	0.000313	0.00106	CcSEcCtD
Fingolimod—Infestation—Capecitabine—kidney cancer	0.000313	0.00106	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000312	0.00106	CcSEcCtD
Fingolimod—Asthenia—Vinblastine—kidney cancer	0.000312	0.00106	CcSEcCtD
Fingolimod—Fatigue—Sunitinib—kidney cancer	0.000312	0.00106	CcSEcCtD
Fingolimod—Depression—Capecitabine—kidney cancer	0.000312	0.00106	CcSEcCtD
Fingolimod—Asthenia—Everolimus—kidney cancer	0.000311	0.00105	CcSEcCtD
Fingolimod—Cough—Gemcitabine—kidney cancer	0.00031	0.00105	CcSEcCtD
Fingolimod—Angiopathy—Paclitaxel—kidney cancer	0.00031	0.00105	CcSEcCtD
Fingolimod—Mediastinal disorder—Paclitaxel—kidney cancer	0.000308	0.00104	CcSEcCtD
Fingolimod—Hypertension—Gemcitabine—kidney cancer	0.000307	0.00104	CcSEcCtD
Fingolimod—Pruritus—Everolimus—kidney cancer	0.000306	0.00104	CcSEcCtD
Fingolimod—Infection—Vincristine—kidney cancer	0.000304	0.00103	CcSEcCtD
Fingolimod—Alopecia—Paclitaxel—kidney cancer	0.000302	0.00102	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000301	0.00102	CcSEcCtD
Fingolimod—Nervous system disorder—Vincristine—kidney cancer	0.0003	0.00102	CcSEcCtD
Fingolimod—Asthenia—Erlotinib—kidney cancer	0.0003	0.00102	CcSEcCtD
Fingolimod—Mental disorder—Paclitaxel—kidney cancer	0.0003	0.00102	CcSEcCtD
Fingolimod—Diarrhoea—Vinblastine—kidney cancer	0.000297	0.00101	CcSEcCtD
Fingolimod—Diarrhoea—Everolimus—kidney cancer	0.000296	0.001	CcSEcCtD
Fingolimod—Pruritus—Erlotinib—kidney cancer	0.000296	0.001	CcSEcCtD
Fingolimod—Fatigue—Dactinomycin—kidney cancer	0.000295	0.001	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—kidney cancer	0.000291	0.000986	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—kidney cancer	0.00029	0.000982	CcSEcCtD
Fingolimod—Infection—Gemcitabine—kidney cancer	0.000288	0.000977	CcSEcCtD
Fingolimod—Back pain—Paclitaxel—kidney cancer	0.000288	0.000976	CcSEcCtD
Fingolimod—Dizziness—Vinblastine—kidney cancer	0.000287	0.000974	CcSEcCtD
Fingolimod—Dizziness—Everolimus—kidney cancer	0.000286	0.000971	CcSEcCtD
Fingolimod—Diarrhoea—Erlotinib—kidney cancer	0.000286	0.000969	CcSEcCtD
Fingolimod—Hypotension—Vincristine—kidney cancer	0.000286	0.000969	CcSEcCtD
Fingolimod—Bradycardia—Capecitabine—kidney cancer	0.000286	0.000968	CcSEcCtD
Fingolimod—Nervous system disorder—Gemcitabine—kidney cancer	0.000285	0.000965	CcSEcCtD
Fingolimod—Skin disorder—Gemcitabine—kidney cancer	0.000282	0.000955	CcSEcCtD
Fingolimod—Vision blurred—Paclitaxel—kidney cancer	0.000281	0.000951	CcSEcCtD
Fingolimod—Dizziness—Erlotinib—kidney cancer	0.000276	0.000936	CcSEcCtD
Fingolimod—Connective tissue disorder—Capecitabine—kidney cancer	0.000276	0.000935	CcSEcCtD
Fingolimod—Paraesthesia—Vincristine—kidney cancer	0.000275	0.000931	CcSEcCtD
Fingolimod—Headache—Vinblastine—kidney cancer	0.000272	0.000923	CcSEcCtD
Fingolimod—Headache—Everolimus—kidney cancer	0.000271	0.000919	CcSEcCtD
Fingolimod—Hypotension—Gemcitabine—kidney cancer	0.000271	0.000919	CcSEcCtD
Fingolimod—Asthenia—Sorafenib—kidney cancer	0.00027	0.000914	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000267	0.000904	CcSEcCtD
Fingolimod—Leukopenia—Paclitaxel—kidney cancer	0.000267	0.000903	CcSEcCtD
Fingolimod—Pruritus—Sorafenib—kidney cancer	0.000266	0.000901	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vincristine—kidney cancer	0.000264	0.000895	CcSEcCtD
Fingolimod—Fatigue—Vincristine—kidney cancer	0.000264	0.000894	CcSEcCtD
Fingolimod—Palpitations—Paclitaxel—kidney cancer	0.000263	0.000892	CcSEcCtD
Fingolimod—Eye disorder—Capecitabine—kidney cancer	0.000262	0.000889	CcSEcCtD
Fingolimod—Headache—Erlotinib—kidney cancer	0.000262	0.000887	CcSEcCtD
Fingolimod—Paraesthesia—Gemcitabine—kidney cancer	0.000261	0.000883	CcSEcCtD
Fingolimod—Cardiac disorder—Capecitabine—kidney cancer	0.000261	0.000883	CcSEcCtD
Fingolimod—Cough—Paclitaxel—kidney cancer	0.00026	0.000881	CcSEcCtD
Fingolimod—Asthenia—Sunitinib—kidney cancer	0.00026	0.00088	CcSEcCtD
Fingolimod—Dyspnoea—Gemcitabine—kidney cancer	0.000259	0.000877	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—kidney cancer	0.000257	0.000872	CcSEcCtD
Fingolimod—Diarrhoea—Sorafenib—kidney cancer	0.000257	0.000872	CcSEcCtD
Fingolimod—Hypertension—Paclitaxel—kidney cancer	0.000257	0.000871	CcSEcCtD
Fingolimod—Pruritus—Sunitinib—kidney cancer	0.000256	0.000867	CcSEcCtD
Fingolimod—Angiopathy—Capecitabine—kidney cancer	0.000255	0.000863	CcSEcCtD
Fingolimod—Mediastinal disorder—Capecitabine—kidney cancer	0.000253	0.000857	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000252	0.000853	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000251	0.000849	CcSEcCtD
Fingolimod—Fatigue—Gemcitabine—kidney cancer	0.00025	0.000848	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—kidney cancer	0.000249	0.000843	CcSEcCtD
Fingolimod—Dizziness—Sorafenib—kidney cancer	0.000249	0.000842	CcSEcCtD
Fingolimod—Alopecia—Capecitabine—kidney cancer	0.000248	0.000841	CcSEcCtD
Fingolimod—Diarrhoea—Sunitinib—kidney cancer	0.000248	0.000839	CcSEcCtD
Fingolimod—Mental disorder—Capecitabine—kidney cancer	0.000246	0.000833	CcSEcCtD
Fingolimod—Asthenia—Dactinomycin—kidney cancer	0.000246	0.000833	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—kidney cancer	0.000241	0.000818	CcSEcCtD
Fingolimod—Infection—Paclitaxel—kidney cancer	0.000241	0.000818	CcSEcCtD
Fingolimod—Dizziness—Sunitinib—kidney cancer	0.000239	0.000811	CcSEcCtD
Fingolimod—Nervous system disorder—Paclitaxel—kidney cancer	0.000238	0.000808	CcSEcCtD
Fingolimod—Back pain—Capecitabine—kidney cancer	0.000236	0.000801	CcSEcCtD
Fingolimod—Skin disorder—Paclitaxel—kidney cancer	0.000236	0.0008	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000236	0.000798	CcSEcCtD
Fingolimod—Headache—Sorafenib—kidney cancer	0.000236	0.000798	CcSEcCtD
Fingolimod—Diarrhoea—Dactinomycin—kidney cancer	0.000234	0.000794	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000231	0.000782	CcSEcCtD
Fingolimod—Vision blurred—Capecitabine—kidney cancer	0.00023	0.00078	CcSEcCtD
Fingolimod—Hypotension—Paclitaxel—kidney cancer	0.000227	0.00077	CcSEcCtD
Fingolimod—Headache—Sunitinib—kidney cancer	0.000227	0.000768	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—kidney cancer	0.000226	0.000766	CcSEcCtD
Fingolimod—Asthenia—Vincristine—kidney cancer	0.00022	0.000744	CcSEcCtD
Fingolimod—Leukopenia—Capecitabine—kidney cancer	0.000219	0.000741	CcSEcCtD
Fingolimod—Paraesthesia—Paclitaxel—kidney cancer	0.000218	0.000739	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—kidney cancer	0.000217	0.000737	CcSEcCtD
Fingolimod—Dyspnoea—Paclitaxel—kidney cancer	0.000217	0.000734	CcSEcCtD
Fingolimod—Palpitations—Capecitabine—kidney cancer	0.000216	0.000732	CcSEcCtD
Fingolimod—Cough—Capecitabine—kidney cancer	0.000213	0.000723	CcSEcCtD
Fingolimod—Hypertension—Capecitabine—kidney cancer	0.000211	0.000715	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00021	0.000711	CcSEcCtD
Fingolimod—Fatigue—Paclitaxel—kidney cancer	0.00021	0.00071	CcSEcCtD
Fingolimod—Diarrhoea—Vincristine—kidney cancer	0.000209	0.000709	CcSEcCtD
Fingolimod—Asthenia—Gemcitabine—kidney cancer	0.000208	0.000706	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000207	0.0007	CcSEcCtD
Fingolimod—Pruritus—Gemcitabine—kidney cancer	0.000205	0.000696	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—kidney cancer	0.000205	0.000693	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—kidney cancer	0.000203	0.000687	CcSEcCtD
Fingolimod—Dizziness—Vincristine—kidney cancer	0.000202	0.000686	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—kidney cancer	0.000202	0.000683	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—kidney cancer	0.000202	0.000683	CcSEcCtD
Fingolimod—Diarrhoea—Gemcitabine—kidney cancer	0.000199	0.000673	CcSEcCtD
Fingolimod—Infection—Capecitabine—kidney cancer	0.000198	0.000671	CcSEcCtD
Fingolimod—Nervous system disorder—Capecitabine—kidney cancer	0.000196	0.000663	CcSEcCtD
Fingolimod—Skin disorder—Capecitabine—kidney cancer	0.000194	0.000656	CcSEcCtD
Fingolimod—Headache—Vincristine—kidney cancer	0.000192	0.00065	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—kidney cancer	0.000189	0.000641	CcSEcCtD
Fingolimod—Hypotension—Capecitabine—kidney cancer	0.000186	0.000631	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—kidney cancer	0.000184	0.000624	CcSEcCtD
Fingolimod—Headache—Gemcitabine—kidney cancer	0.000182	0.000616	CcSEcCtD
Fingolimod—Paraesthesia—Capecitabine—kidney cancer	0.000179	0.000607	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—kidney cancer	0.000178	0.000603	CcSEcCtD
Fingolimod—Dyspnoea—Capecitabine—kidney cancer	0.000178	0.000603	CcSEcCtD
Fingolimod—Asthenia—Paclitaxel—kidney cancer	0.000174	0.000591	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000172	0.000583	CcSEcCtD
Fingolimod—Fatigue—Capecitabine—kidney cancer	0.000172	0.000583	CcSEcCtD
Fingolimod—Pruritus—Paclitaxel—kidney cancer	0.000172	0.000583	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—kidney cancer	0.000169	0.000573	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—kidney cancer	0.000168	0.000569	CcSEcCtD
Fingolimod—Diarrhoea—Paclitaxel—kidney cancer	0.000166	0.000563	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—kidney cancer	0.000164	0.000556	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—kidney cancer	0.000163	0.000553	CcSEcCtD
Fingolimod—Dizziness—Paclitaxel—kidney cancer	0.000161	0.000545	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—kidney cancer	0.00016	0.000542	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—kidney cancer	0.000159	0.000537	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—kidney cancer	0.000152	0.000516	CcSEcCtD
Fingolimod—Headache—Paclitaxel—kidney cancer	0.000152	0.000516	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—kidney cancer	0.000148	0.000503	CcSEcCtD
Fingolimod—Asthenia—Capecitabine—kidney cancer	0.000143	0.000485	CcSEcCtD
Fingolimod—Pruritus—Capecitabine—kidney cancer	0.000141	0.000478	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—kidney cancer	0.000141	0.000478	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—kidney cancer	0.000139	0.000472	CcSEcCtD
Fingolimod—Cough—Doxorubicin—kidney cancer	0.000137	0.000466	CcSEcCtD
Fingolimod—Diarrhoea—Capecitabine—kidney cancer	0.000136	0.000462	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—kidney cancer	0.000136	0.000461	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000133	0.000451	CcSEcCtD
Fingolimod—Dizziness—Capecitabine—kidney cancer	0.000132	0.000447	CcSEcCtD
Fingolimod—Infection—Doxorubicin—kidney cancer	0.000128	0.000433	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—kidney cancer	0.000126	0.000427	CcSEcCtD
Fingolimod—Headache—Capecitabine—kidney cancer	0.000125	0.000423	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—kidney cancer	0.000125	0.000423	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—kidney cancer	0.00012	0.000407	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—kidney cancer	0.000115	0.000391	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—kidney cancer	0.000115	0.000388	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000111	0.000376	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—kidney cancer	0.000111	0.000376	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—kidney cancer	9.22e-05	0.000313	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—kidney cancer	9.1e-05	0.000308	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—kidney cancer	8.8e-05	0.000298	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—kidney cancer	8.5e-05	0.000288	CcSEcCtD
Fingolimod—Headache—Doxorubicin—kidney cancer	8.05e-05	0.000273	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—PTGS2—kidney cancer	5.36e-05	0.000252	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BRAF—kidney cancer	5.32e-05	0.00025	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTP1—kidney cancer	5.23e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—MAPK3—kidney cancer	5.22e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—MAPK3—kidney cancer	5.22e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—POMC—kidney cancer	5.19e-05	0.000243	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—POMC—kidney cancer	5.19e-05	0.000243	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—MAPK1—kidney cancer	5.16e-05	0.000242	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	5.16e-05	0.000242	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.16e-05	0.000242	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BRAF—kidney cancer	5.12e-05	0.00024	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BRAF—kidney cancer	5.12e-05	0.00024	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—POMC—kidney cancer	4.99e-05	0.000234	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HIF1A—kidney cancer	4.97e-05	0.000233	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—MAPK1—kidney cancer	4.97e-05	0.000233	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—MAPK1—kidney cancer	4.97e-05	0.000233	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TSC2—kidney cancer	4.96e-05	0.000233	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APC—kidney cancer	4.95e-05	0.000232	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KIT—kidney cancer	4.95e-05	0.000232	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.93e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CA—kidney cancer	4.93e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—kidney cancer	4.88e-05	0.000229	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTM1—kidney cancer	4.81e-05	0.000225	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PDHB—kidney cancer	4.8e-05	0.000225	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—POMC—kidney cancer	4.79e-05	0.000224	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KDR—kidney cancer	4.76e-05	0.000223	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CA—kidney cancer	4.75e-05	0.000223	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CA—kidney cancer	4.75e-05	0.000223	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—MAPK3—kidney cancer	4.74e-05	0.000222	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.74e-05	0.000222	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—POMC—kidney cancer	4.71e-05	0.000221	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—kidney cancer	4.69e-05	0.00022	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—kidney cancer	4.69e-05	0.00022	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTEN—kidney cancer	4.68e-05	0.000219	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BRAF—kidney cancer	4.65e-05	0.000218	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—kidney cancer	4.63e-05	0.000217	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.62e-05	0.000217	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.56e-05	0.000214	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CCBL1—kidney cancer	4.52e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—MAPK1—kidney cancer	4.51e-05	0.000212	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	4.49e-05	0.000211	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CA—kidney cancer	4.48e-05	0.00021	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RAF1—kidney cancer	4.45e-05	0.000208	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RELA—kidney cancer	4.43e-05	0.000208	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—kidney cancer	4.4e-05	0.000206	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KIT—kidney cancer	4.38e-05	0.000205	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APC—kidney cancer	4.38e-05	0.000205	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MTOR—kidney cancer	4.34e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—kidney cancer	4.31e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—kidney cancer	4.31e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—kidney cancer	4.31e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RAF1—kidney cancer	4.28e-05	0.000201	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RAF1—kidney cancer	4.28e-05	0.000201	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—kidney cancer	4.26e-05	0.0002	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RELA—kidney cancer	4.26e-05	0.0002	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RELA—kidney cancer	4.26e-05	0.0002	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—kidney cancer	4.23e-05	0.000198	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—kidney cancer	4.23e-05	0.000198	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.18e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MTOR—kidney cancer	4.18e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MTOR—kidney cancer	4.18e-05	0.000196	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—POMC—kidney cancer	4.17e-05	0.000196	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BRAF—kidney cancer	4.12e-05	0.000193	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1B—kidney cancer	4.07e-05	0.000191	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTEN—kidney cancer	4.04e-05	0.000189	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACY1—kidney cancer	4.01e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—kidney cancer	3.99e-05	0.000187	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—kidney cancer	3.98e-05	0.000187	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—kidney cancer	3.92e-05	0.000184	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—kidney cancer	3.92e-05	0.000184	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GLIPR1—kidney cancer	3.92e-05	0.000184	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPAT—kidney cancer	3.92e-05	0.000184	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—kidney cancer	3.91e-05	0.000184	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RAF1—kidney cancer	3.89e-05	0.000182	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—kidney cancer	3.89e-05	0.000182	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JUN—kidney cancer	3.88e-05	0.000182	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RELA—kidney cancer	3.87e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—kidney cancer	3.85e-05	0.00018	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—kidney cancer	3.84e-05	0.00018	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—kidney cancer	3.84e-05	0.00018	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—kidney cancer	3.84e-05	0.00018	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MTOR—kidney cancer	3.79e-05	0.000178	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—kidney cancer	3.75e-05	0.000176	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—kidney cancer	3.74e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—kidney cancer	3.74e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JUN—kidney cancer	3.73e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JUN—kidney cancer	3.73e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—kidney cancer	3.7e-05	0.000174	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—kidney cancer	3.7e-05	0.000174	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FH—kidney cancer	3.64e-05	0.000171	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APRT—kidney cancer	3.64e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—kidney cancer	3.61e-05	0.000169	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—kidney cancer	3.61e-05	0.000169	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—kidney cancer	3.56e-05	0.000167	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—kidney cancer	3.48e-05	0.000163	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—kidney cancer	3.47e-05	0.000163	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RAF1—kidney cancer	3.44e-05	0.000161	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RELA—kidney cancer	3.42e-05	0.000161	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPC3—kidney cancer	3.42e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.42e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PDHB—kidney cancer	3.41e-05	0.00016	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—kidney cancer	3.4e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—POMC—kidney cancer	3.4e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—kidney cancer	3.4e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JUN—kidney cancer	3.39e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—kidney cancer	3.39e-05	0.000159	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.37e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—kidney cancer	3.36e-05	0.000158	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MTOR—kidney cancer	3.36e-05	0.000157	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA2—kidney cancer	3.33e-05	0.000156	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—kidney cancer	3.3e-05	0.000155	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—kidney cancer	3.28e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—kidney cancer	3.26e-05	0.000153	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—kidney cancer	3.26e-05	0.000153	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALAD—kidney cancer	3.24e-05	0.000152	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CCBL1—kidney cancer	3.2e-05	0.00015	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK3—kidney cancer	3.2e-05	0.00015	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ST3GAL2—kidney cancer	3.17e-05	0.000148	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—kidney cancer	3.15e-05	0.000148	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.14e-05	0.000147	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—kidney cancer	3.12e-05	0.000146	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.1e-05	0.000145	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDH1A1—kidney cancer	3.1e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK3—kidney cancer	3.08e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK3—kidney cancer	3.08e-05	0.000145	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—kidney cancer	3.08e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK1—kidney cancer	3.05e-05	0.000143	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—kidney cancer	3.01e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—kidney cancer	3e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—kidney cancer	3e-05	0.000141	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JUN—kidney cancer	3e-05	0.000141	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.98e-05	0.00014	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—kidney cancer	2.98e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A3—kidney cancer	2.97e-05	0.000139	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PGK1—kidney cancer	2.97e-05	0.000139	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—kidney cancer	2.96e-05	0.000139	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.94e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK1—kidney cancer	2.94e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK1—kidney cancer	2.94e-05	0.000138	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LDHB—kidney cancer	2.91e-05	0.000136	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—kidney cancer	2.9e-05	0.000136	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—kidney cancer	2.88e-05	0.000135	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—kidney cancer	2.85e-05	0.000134	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK3—kidney cancer	2.8e-05	0.000131	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.78e-05	0.00013	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPAT—kidney cancer	2.78e-05	0.00013	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—kidney cancer	2.77e-05	0.00013	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—kidney cancer	2.77e-05	0.00013	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—kidney cancer	2.72e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK1—kidney cancer	2.67e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—kidney cancer	2.65e-05	0.000124	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACY1—kidney cancer	2.62e-05	0.000123	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—kidney cancer	2.62e-05	0.000123	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APRT—kidney cancer	2.58e-05	0.000121	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FH—kidney cancer	2.58e-05	0.000121	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—kidney cancer	2.56e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—kidney cancer	2.55e-05	0.000119	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—kidney cancer	2.55e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA9—kidney cancer	2.52e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—kidney cancer	2.52e-05	0.000118	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—kidney cancer	2.48e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—kidney cancer	2.46e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—kidney cancer	2.46e-05	0.000116	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—kidney cancer	2.45e-05	0.000115	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPC3—kidney cancer	2.43e-05	0.000114	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—kidney cancer	2.41e-05	0.000113	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA2—kidney cancer	2.36e-05	0.000111	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK1—kidney cancer	2.36e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—kidney cancer	2.31e-05	0.000108	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALAD—kidney cancer	2.3e-05	0.000108	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.25e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—kidney cancer	2.24e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PDHB—kidney cancer	2.23e-05	0.000104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—kidney cancer	2.23e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—POMC—kidney cancer	2.22e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.2e-05	0.000103	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CRABP1—kidney cancer	2.15e-05	0.000101	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.11e-05	9.87e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PGK1—kidney cancer	2.11e-05	9.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CCBL1—kidney cancer	2.1e-05	9.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LDHB—kidney cancer	2.07e-05	9.68e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—kidney cancer	2.05e-05	9.6e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ITPR2—kidney cancer	1.99e-05	9.35e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—kidney cancer	1.98e-05	9.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—kidney cancer	1.82e-05	8.53e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ACHE—kidney cancer	1.82e-05	8.53e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.82e-05	8.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPAT—kidney cancer	1.82e-05	8.52e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA9—kidney cancer	1.79e-05	8.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SCARB1—kidney cancer	1.72e-05	8.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS1—kidney cancer	1.7e-05	7.99e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FH—kidney cancer	1.69e-05	7.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APRT—kidney cancer	1.69e-05	7.92e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSMD7—kidney cancer	1.67e-05	7.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPC3—kidney cancer	1.59e-05	7.44e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BCHE—kidney cancer	1.58e-05	7.43e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.57e-05	7.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA2—kidney cancer	1.54e-05	7.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CRABP1—kidney cancer	1.52e-05	7.14e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.51e-05	7.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALAD—kidney cancer	1.51e-05	7.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.47e-05	6.89e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.44e-05	6.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ITPR2—kidney cancer	1.42e-05	6.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.38e-05	6.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PGK1—kidney cancer	1.38e-05	6.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LDHB—kidney cancer	1.35e-05	6.33e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—kidney cancer	1.29e-05	6.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACHE—kidney cancer	1.29e-05	6.05e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—kidney cancer	1.26e-05	5.91e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SCARB1—kidney cancer	1.22e-05	5.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS1—kidney cancer	1.21e-05	5.67e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—kidney cancer	1.19e-05	5.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSMD7—kidney cancer	1.19e-05	5.56e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA9—kidney cancer	1.17e-05	5.49e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—kidney cancer	1.16e-05	5.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BCHE—kidney cancer	1.12e-05	5.27e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.11e-05	5.21e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.1e-05	5.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.07e-05	5.03e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CRABP1—kidney cancer	9.95e-06	4.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ITPR2—kidney cancer	9.25e-06	4.34e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—kidney cancer	8.95e-06	4.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—kidney cancer	8.47e-06	3.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACHE—kidney cancer	8.44e-06	3.96e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—kidney cancer	8.44e-06	3.96e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—kidney cancer	8.22e-06	3.85e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—POMC—kidney cancer	8.19e-06	3.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SCARB1—kidney cancer	7.99e-06	3.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS1—kidney cancer	7.91e-06	3.71e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.79e-06	3.65e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSMD7—kidney cancer	7.75e-06	3.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BCHE—kidney cancer	7.35e-06	3.45e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.26e-06	3.4e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.01e-06	3.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—kidney cancer	6.53e-06	3.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—kidney cancer	5.85e-06	2.74e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—POMC—kidney cancer	5.81e-06	2.72e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—kidney cancer	5.7e-06	2.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—kidney cancer	5.54e-06	2.6e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—kidney cancer	5.37e-06	2.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.1e-06	2.39e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—kidney cancer	4.63e-06	2.17e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—kidney cancer	4.04e-06	1.9e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.02e-06	1.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—POMC—kidney cancer	3.8e-06	1.78e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—kidney cancer	3.03e-06	1.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.85e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—kidney cancer	2.64e-06	1.24e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.86e-06	8.74e-06	CbGpPWpGaD
